FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Atelvia (risendronate sodium) submitted by Allergan, Inc., to update/expand the product labeling related to its use …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• ATELVIA (RISENDRONATE SODIUM)

Snippet

SUPPL AP for ATELVIA (RISEDRONATE SODIUM)